Market Cap

Medtronic Market Capitalization:

Medtronic plc

$117.30 Billion

USD as of July 1, 2023

business Medtronic Company Profile

Medtronic Main Stock Listing

show_chart NYSE: MDT

Market capitalization history of Medtronic

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $185.81 B
Stryker Corporation $111.71 B
Boston Scientific Corporation $75.41 B
Edwards Lifesciences Corporation $56.44 B
Shenzhen Mindray Bio-Medical Electronics Co. Ltd $49.16 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Medtronic market cap

Date Market Cap YoY Change
Jan. 1, 2023 $103.38 B -22.73%
Jan. 1, 2022 $133.79 B -7.04%
Jan. 1, 2021 $143.92 B -3.56%
Jan. 1, 2020 $149.24 B 30.60%
Jan. 1, 2019 $114.27 B 2.91%
Jan. 1, 2018 $111.03 B 12.98%
Jan. 1, 2017 $98.28 B 0.13%
Jan. 1, 2016 $98.15 B 6.33%
Jan. 1, 2015 $92.30 B 26.24%
Jan. 1, 2014 $73.12 B 21.37%
Jan. 1, 2013 $60.24 B 20.82%
Jan. 1, 2012 $49.86 B 0.65%
Jan. 1, 2011 $49.54 B -10.66%
Jan. 1, 2010 $55.45 B 28.07%
Jan. 1, 2009 $43.29 B -27.98%
Jan. 1, 2008 $60.11 B -13.00%
Jan. 1, 2007 $69.10 B -5.35%
Jan. 1, 2006 $73.00 B 7.58%
Jan. 1, 2005 $67.86 B 6.64%
Jan. 1, 2004 $63.63 B 9.57%
Jan. 1, 2003 $58.07 B -8.83%
Jan. 1, 2002 $63.69 B -8.76%
Jan. 1, 2001 $69.81 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Medtronic Categories

Ireland languages Healthcare languages Medical Devices
Ireland Healthcare Ireland Medical Devices

Stocks & Indices

Medtronic plc has the following listings and related stock indices.


Stock: NYSE: MDT

Stock: BCBA: MDT

Stock: Bovespa: MDTC34

Stock: FSX: 2M6

Stock: XETR: 2M6

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.